CAI (Caris Life Sciences) FCF Margin %: 10.42% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI Caris Life Sciences Inc CAI
11 GF Score
Price $15.53
! 2 Warning Signs
View Full Analysis

What is Caris Life Sciences FCF Margin %?

Caris Life Sciences CAI -0.89% 11 FCF Margin % is 10.42% as of Mar. 2026. GuruFocus rates CAI with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 950 Biotechnology companies, Caris Life Sciences ranks better than 85.47% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Caris Life Sciences's Free Cash Flow for the three months ended in Mar. 2026 was $22.5 Mil. Caris Life Sciences's Revenue for the three months ended in Mar. 2026 was $216.2 Mil. Therefore, Caris Life Sciences's FCF Margin % for the quarter that ended in Mar. 2026 was 10.42%.

As of today, Caris Life Sciences's current FCF Yield % is 2.81%.

The historical rank and industry rank for Caris Life Sciences's FCF Margin % or its related term are showing as below:

CAI' s FCF Margin % Range Over the Past 10 Years
Min: -126.88   Med: -79.51   Max: 13.61
Current: 13.61

During the past 4 years, the highest FCF Margin % of Caris Life Sciences was 13.61%. The lowest was -126.88%. And the median was -79.51%.

CAI's FCF Margin % is ranked better than
85.47% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs CAI: 13.61

Caris Life Sciences FCF Margin % Related Terms

Caris Life Sciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Caris Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caris Life Sciences FCF Margin % Chart

Caris Life Sciences Annual Data
Trend Dec22 Dec23 Dec24 Dec25
FCF Margin %
-126.88 -97.48 -61.53 8.24

Caris Life Sciences Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -28.14 3.25 25.52 13.55 10.42

CAI vs DNTH, MANE, TNGX: FCF Margin % Comparison

For the Biotechnology subindustry, Caris Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Caris Life Sciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Caris Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Caris Life Sciences's FCF Margin % falls into.


CAI
11GF Score
Caris Life Sciences Inc CAI
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Caris Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Caris Life Sciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=66.895/812.033
=8.24 %

Caris Life Sciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=22.534/216.174
=10.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 10.42% mean?
Caris Life Sciences (CAI) has a FCF Margin % of 10.42% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Caris Life Sciences and its competitors. According to the industry distribution chart, Caris Life Sciences ranks #138 out of 950 companies in the Biotechnology industry, placing it in the top 14.5%.
Is Caris Life Sciences' FCF Margin % too high?
Caris Life Sciences' current FCF Margin % is 10.42%. Based on the distribution chart, Caris Life Sciences ranks #138 out of 950 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Caris Life Sciences has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Caris Life Sciences' FCF Margin % compare to DNTH and MANE?
According to the Biotechnology industry distribution chart, Caris Life Sciences ranks #138 out of 950 companies for FCF Margin %. This places Caris Life Sciences in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Caris Life Sciences and its competitors. Caris Life Sciences's current FCF Margin % is 10.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caris Life Sciences stock overvalued right now?
Caris Life Sciences (CAI) has a current FCF Margin % of 10.42%. The current FCF Margin % is 10.42%. Caris Life Sciences' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Caris Life Sciences (CAI), the current FCF Margin % is 10.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Caris Life Sciences Business Description

Other Exchanges CAI:Mexico49J:Germany
Address 750 W. John Carpenter Freeway, Suite 800, Irving, TX, USA, 75039
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
11GF Score

Get the complete analysis for CAI

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.53
Price